Roche

Roche

Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

HQ location
Basel, Switzerland
Website
roche.com
Launch date
Employees
1 people
Market cap
$192.3b
Enterprise value
$209.8b
Share price
CHF258.40 ROG.SW
Company register number
CHE-105.815.381
Recent deals
Corporate Venture Fund
Roche Venture Fund
https://twitter.com/rochehttps://www.facebook.com/rochecareershttps://www.linkedin.com/company/rochehttps://apps.apple.com/app/id1102471373https://play.google.com/store/apps/details?id=eg.com.cat.roche
    • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*
N/A

$5.5b

Post IPO Debt
Total Funding000k
5AM Ventures
5AM Ventures(exited)
Gilde Healthcare
Gilde Healthcare(exited)
Wellington Partners
Wellington Partners(exited)
SoftBank
SoftBank(exited)
Droia Oncology Ventures
Droia Oncology Ventures(exited)
Quest for Growth
Quest for Growth(exited)
Sofinnova
Sofinnova(exited)
SCALE AI
SCALE AI(exited)
Novi Management
Novi Management

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
CHF2021202220232024202520262027
Revenues0000000000000000000000000000
% growth8 %1 %(4 %)3 %1 %4 %3 %
EBITDA0000000000000000000000000000
% EBITDA margin36 %34 %31 %27 %40 %40 %41 %
Profit0000000000000000000000000000
% profit margin22 %20 %19 %13 %22 %23 %24 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue24 %25 %23 %25 %---

Source: Company filings or news article, Equity research estimates

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit
By Country
United States 16Germany 3Austria 1Canada 1France 1Denmark 1Ireland 1United Kingdom 1Italy 1Switzerland 1Israel 1
By Industry
Health 26Telecom 1Enterprise Software 1
By Round
ACQUISITION 20SEED 2SERIES A 2EARLY VC 1POST IPO EQUITY 1LATE VC 1SERIES C 1

Investments by Roche

Edit
MySugr
MySugr
ACQUISITION by Roche Jun 2017
Spark Therapeutics
Spark Therapeutics
ACQUISITION by Roche Feb 2019
Ignyta
Ignyta
ACQUISITION by Roche Dec 2017
GeneWEAVE
GeneWEAVE
ACQUISITION by Roche Aug 2015
Tensha Therapeutics
Tensha Therapeutics
ACQUISITION by Roche Jan 2016
Arius Research
Arius Research
ACQUISITION by Roche Jul 2008
Flatiron Health
Flatiron Health
ACQUISITION by Roche Venture Fund Feb 2018
Carmot Therapeutics
Carmot Therapeutics
ACQUISITION by Roche Dec 2023
Affimed Therapeutics
Affimed Therapeutics
exited
Trophos
Trophos
ACQUISITION by Roche Jan 2015
View 69 more